Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology. GMAB is an adaptive technology that uses a novel, cell-penetrating antibody to non-covalently bind to and systemically deliver therapeutic levels of a wide variety of nucleic acid payloads to select cells, including mRNA, synthetic RNA, DNA, si-RNA, ASOs and gene-editing molecules. This non-viral delivery platform is differentiated from traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and employs well-established manufacturing processes. Gennao Bio is developing this delivery system with an initial focus on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases.
View Top Employees from Gennao BioWebsite | http://www.gennao.com |
Employees | 35 (35 on RocketReach) |
Founded | 2020 |
Address | 311 Pennington Rocky Hill Rd Bldg 21, Hopewell, New Jersey 08525, US |
Industry | Biotechnology |
Looking for a particular Gennao Bio employee's phone or email?
Dale Ludwig is the Chief Scientific Officer of Gennao Bio.
35 people are employed at Gennao Bio.
Gennao Bio is based in Hopewell, New Jersey.